1. Tea catechins’ affinity for human cannabinoid receptors
- Author
-
Gabriele Korte, Anett Oehme, Sarah Geiger, Jörg Heilmann, Andrea Dreiseitel, Philipp G. Sand, Peter Schreier, and Sanja Locher
- Subjects
Cannabinoid receptor ,Pharmaceutical Science ,Pharmacology ,Ligands ,Neuroprotection ,Camellia sinensis ,Catechin ,Cell Line ,chemistry.chemical_compound ,In vivo ,Drug Discovery ,Humans ,Receptors, Cannabinoid ,Receptor ,Tea ,Cannabinoids ,Plant Extracts ,Chinese hamster ovary cell ,food and beverages ,Biological activity ,Recombinant Proteins ,Plant Leaves ,Complementary and alternative medicine ,chemistry ,Biochemistry ,Molecular Medicine ,lipids (amino acids, peptides, and proteins) ,Signal transduction ,Signal Transduction - Abstract
Among the many known health benefits of tea catechins count anti-inflammatory and neuroprotective activities, as well as effects on the regulation of food intake. Here we address cannabimimetic bioactivity of catechin derivatives occurring in tea leaves as a possible cellular effector of these functionalities. Competitive radioligand binding assays using recombinant human cannabinoid receptors expressed in Chem-1 and CHO cells identified (-)-epigallocatechin-3-O-gallate, EGCG (K(i)=33.6 microM), (-)-epigallocatechin, EGC (K(i)=35.7 microM), and (-)-epicatechin-3-O-gallate, ECG (K(i)=47.3 microM) as ligands with moderate affinity for type 1 cannabinoid receptors, CB1. Binding to CB2 was weaker with inhibition constants exceeding 50 microM for EGC and ECG. The epimers (+)-catechin and (-)-epicatechin exhibited negligible affinities for both CB1 and CB2. It can be concluded that central nervous cannabinoid receptors may be targeted by selected tea catechins but signaling via peripheral type receptors is less likely to play a major role in vivo.
- Published
- 2010